Abstract
Adenosine A2A receptors were cloned about ten years ago and are known to be well conserved among mammals. Rather selective agonists and antagonists are available. In addition, two different knock-out mice have been prepared and extensively characterized. A2A receptors are highly enriched in the basal ganglia and on cells involved in inflammatory reactions. At these sites they are likely to play physiologically important roles. Efforts to develop new therapies based on A2A receptors have focused on these topics. However, A2A receptors are found on many other cell types and on them as well agonists can exert effect.
Keywords: methylxanthines, purines, basal ganglia, inflammation, knock-out
Current Topics in Medicinal Chemistry
Title: Pharmacology of Adenosine A2A Receptors and Therapeutic Applications
Volume: 3 Issue: 4
Author(s): Bertil B. Fredholm, Rodrigo A. Cunha and Per Svenningsson
Affiliation:
Keywords: methylxanthines, purines, basal ganglia, inflammation, knock-out
Abstract: Adenosine A2A receptors were cloned about ten years ago and are known to be well conserved among mammals. Rather selective agonists and antagonists are available. In addition, two different knock-out mice have been prepared and extensively characterized. A2A receptors are highly enriched in the basal ganglia and on cells involved in inflammatory reactions. At these sites they are likely to play physiologically important roles. Efforts to develop new therapies based on A2A receptors have focused on these topics. However, A2A receptors are found on many other cell types and on them as well agonists can exert effect.
Export Options
About this article
Cite this article as:
Fredholm B. Bertil, Cunha A. Rodrigo and Svenningsson Per, Pharmacology of Adenosine A2A Receptors and Therapeutic Applications, Current Topics in Medicinal Chemistry 2003; 3 (4) . https://dx.doi.org/10.2174/1568026033392200
DOI https://dx.doi.org/10.2174/1568026033392200 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update
Current Pharmaceutical Design Noninvasive Monitoring of Intracranial Pressure
Recent Patents on Biomedical Engineering (Discontinued) New Biological Approaches in Asthma: DNA-Based Therapy
Current Medicinal Chemistry Noncardiac Surgery: Evaluating and Minimizing Cardiac Risk
Current Cardiology Reviews Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes
Current Neuropharmacology Progress in Syntheses of 3-n-Butylphthalide and Its Analogues
Current Organic Chemistry Melanocortin Receptors, Melanotropic Peptides and Penile Erection
Current Topics in Medicinal Chemistry Renal Function Impairment in Patients Undergoing Elective EVAR vs. Elective Open Repair During Follow up Period: A Systematic Review of the Literature
Current Vascular Pharmacology Serum Zinc and β D Glucuronidase Enzyme Level in Type 2 Diabetes Mellitus with Periodontitis
Current Diabetes Reviews Pharmacogenetics of the Human MDR1 Multidrug Transporter
Current Pharmacogenomics Monoclonal Antibody Therapy in Haematological Malignancies
Current Clinical Pharmacology Chemistry and Biology of Indoles and Indazoles: A Mini-Review
Mini-Reviews in Medicinal Chemistry COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases
Current Rheumatology Reviews New Agents to Treat Life-Threatening Fungal Infections
Current Topics in Medicinal Chemistry Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition
Current Pharmaceutical Design Physiopathological Roles of P2X Receptors in the Central Nervous System
Current Medicinal Chemistry Metabolite Identification and Profiling in Drug Design: Current Practice and Future Directions
Current Pharmaceutical Design Angiogenic Growth Factors in the Treatment of Peripheral Arterial Disease
Current Vascular Pharmacology Safety Limits of Antidepressant Use Plus Combinations: Focus on Cardiovascular Function
Current Drug Metabolism Fibromyalgia Syndrome: Which Antidepressant Drug Should We Choose
Current Pharmaceutical Design